New Jersey A2537 prohibits prior authorization for prescribing interchangeable drugs if the brand name or generic version is unavailable.
New Jersey A2537 prohibits insurance companies, health service corporations, and other carriers from requiring prior authorization when prescribing interchangeable drugs if the brand name or generic version is not available. This bill aims to ensure that patients can receive necessary medications without unnecessary delays. The act takes effect immediately upon enactment.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
Analyze for Free
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.